Delivery Order SPE2DB22D1106-SPE2DB25FEVB9
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count units) with a ceiling value of $1,117.93. This firm fixed price delivery order, awarded on May 15, 2025, represents a non-set-aside competitive award with an ultimate completion date of May 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $3,768.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Exforge 10-320 mg on July 14, 2025, with completion expected by July 15, 2025. This non-set-aside award represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Exforge 5-320 mg tablets (30-count units) with a ceiling value of $11,807.90. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,525.28 to AmerisourceBergen Drug Corp on May 28, 2025, for the supply of Exforge 5-160 mg tablets (30-count unit). This firm fixed-price contract, with a completion date of May 29, 2025, represents a routine pharmaceutical procurement executed through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from...
- The Defense Logistics Agency awarded a $1,007.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Exforge 5-320 mg on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, which is also the headquarters location of...
- The Defense Logistics Agency awarded a delivery order valued at $2,744.54 to AmerisourceBergen Drug Corp for the supply of Exforge HCT 10-160-12.5 mg tablets (30-count bottles) on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order was placed without set-aside designation and represents a single pharmaceutical supply transaction under the company's existing contract vehicle. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Exforge 5-160 mg tablets (30-count units) with a contract ceiling value of $2,250.48. This firm fixed-price delivery order, with an ultimate completion date of September 22, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, leveraging the company's...
- The Defense Logistics Agency awarded a $2,699.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Exforge 5-320 mg tablets (30-count). This non-set-aside, competitively awarded delivery order is scheduled for completion by November 3, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- The Defense Logistics Agency awarded a $2,682.39 delivery order to AmerisourceBergen Drug Corp for Exforge 10-320 mg tablets (30 count) on July 21, 2025, with completion scheduled for July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,701.12 to AmerisourceBergen Drug Corp for the supply of Exforge HCT 5-160-12.5 mg tablets (30-count package), a combination antihypertensive medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on September 22, 2025, with an ultimate completion date of September 23, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEVB9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,524.91 to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count units) on June 25, 2025, with completion targeted for June 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products, medical devices, and healthcare commodities to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, AmerisourceBergen fulfills critical medical procurement needs across multiple therapeutic domains through DLA's Medical Supply Chain, demonstrating its capability to meet federal procurement requirements in open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 6/25/25 |